Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2010 Jan 13;132(1):371-83.
doi: 10.1021/ja908626k.

Chemical and biological studies of nakiterpiosin and nakiterpiosinone

Affiliations

Chemical and biological studies of nakiterpiosin and nakiterpiosinone

Shuanhu Gao et al. J Am Chem Soc. .

Abstract

Nakiterpiosin and nakiterpiosinone are two related C-nor-D-homosteroids isolated from the sponge Terpios hoshinota that show promise as anticancer agents. We have previously described the asymmetric synthesis and revision of the relative configuration of nakiterpiosin. We now provide detailed information on the stereochemical analysis that supports our structure revision and the synthesis of the originally proposed and revised nakiterpiosin. In addition, we herein describe a refined approach for the synthesis of nakiterpiosin, the first synthesis of nakiterpiosinone, and preliminary mechanistic studies of nakiterpiosin's action in mammalian cells. Cells treated with nakiterpiosin exhibit compromised formation of the primary cilium, an organelle that functions as an assembly point for components of the Hedgehog signal transduction pathway. We provide evidence that the biological effects exhibited by nakiterpiosin are mechanistically distinct from those of well-established antimitotic agents such as taxol. Nakiterpiosin may be useful as an anticancer agent in those tumors resistant to existing antimitotic agents and those dependent on Hedgehog pathway responses for growth.

PubMed Disclaimer

Figures

Figure 1
Figure 1
The structures of C-nor-D-homosteroids 16.
Figure 2
Figure 2
Probing the C-20/C-22/C-23 configurations of nakiterpiosin and nakiterpiosinone.
Figure 3
Figure 3
Probing the C-25 configurations of nakiterpiosin and nakiterpiosinone.
Figure 4
Figure 4
Biogenetic analysis of nakiterpiosin.
Figure 5
Figure 5
The retrosynthetic analysis of nakiterpiosin.
Scheme 1
Scheme 1
Synthesis of the electrophilic coupling component 30.
Scheme 2
Scheme 2
Synthesis of the nucleophilic coupling component 47.
Scheme 3
Scheme 3
Model studies for the carbonylative coupling/Nazarov cyclization strategy.
Scheme 4
Scheme 4
Completion of the synthesis of nakiterpiosin (1).
Scheme 5
Scheme 5
An improved synthesis of nakiterpiosin (1).
Scheme 6
Scheme 6
Synthesis of 64 (6-epi-30).
Scheme 7
Scheme 7
Synthesis of the 6,20,25-epi-nakiterpiosin (3).
Figure 6
Figure 6
Difference in the chemical shifts of the 1H NMR spectra of 1, 3 and the natural product.
Figure 7
Figure 7
Difference in the chemical shifts of the 13C NMR spectra of 1, 3 and the natural product.
Scheme 8
Scheme 8
Rearrangement of the [2.2.1] bicyclic system.
Scheme 9
Scheme 9
Synthesis of nakiterpiosinone (2).
Figure 8
Figure 8
Effects of nakiterpiosin on Hh signaling and primary cilia. (A) The Hh pathway response of Light2 cells (NIH3T3 cells with a Hh-specific firefly luciferase reporter) in the presence of nakiterpiosin. (B) NIH3T3 cells treated with nakiterpiosin showing a compromised ability to form primary cilia, as detected by anti-acetylated tubulin antibody.
Figure 9
Figure 9
The DNA profiles of nakiterpiosin treated HeLa cells.
Figure 10
Figure 10
The in vitro tubulin polymerization assays.

Similar articles

Cited by

References

    1. Plucer-Rosario G. Coral Reefs. 1987;5:197–200.
    2. Rützler K, Smith KP. Sci. Mar. 1993;57:381–393.
    3. Rützler K, Smith KP. Sci. Mar. 1993;57:395–403.
    4. Liao M-H, Tang S-L, Hsu C-M, Wen K-C, Wu H, Chen W-M, Wang J-T, Meng P-J, Twan W-H, Lu C-K, Dai C-F, Soong K, Chen C-A. Zool. Stud. 2007;46:520.
    5. Lin W.-j., M.S. Thesis. National Sun Yat-sen University, Kaohsiung; Taiwan, R.O.C.: 2009.
    1. Teruya T, Nakagawa S, Koyama T, Suenaga K, Kita M, Uemura D. Tetreahedron Lett. 2003;44:5171–5173.
    2. Teruya T, Nakagawa S, Koyama T, Arimoto H, Kita M, Uemura D. Tetreahedron. 2004;60:6989–6993.
    1. Gao S, Wang Q, Chen C. J. Am. Chem. Soc. 2009;131:1410–1412. - PMC - PubMed
    1. Binns W, James LF, Keeler RF, Balls LD. Cancer Res. 1968;28:2323–2326. - PubMed
    2. Keeler RF. Lipids. 1978;13:708–715. - PubMed
    3. James LF. J. Nat. Toxins. 1999;8:63–80. - PubMed
    1. Cooper MK, Porter JA, Young KE, Beachy PA. Science. 1998;280:1603–1607. - PubMed
    2. Incardona JP, Gaffield W, Kapur RP, Roelink H. Development. 1998;125:3553–3562. - PubMed
    3. Chen JK, Taipale J, Cooper MK, Beachy PA. Gen. Dev. 2002;16:2743–2748. - PMC - PubMed
    4. Wang Y, Zhou Z, Walsh CT, McMahon AP. Proc. Natl. Acad. Sci. U.S.A. 2009;106:2623–2628. - PMC - PubMed
    5. Rohatgi R, Milenkovic L, Corcoran RB, Scott MP. Proc. Natl. Acad. Sci. U.S.A. 2009;106:3196–3201. - PMC - PubMed

Publication types